These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 14569140)

  • 1. BRCA1 c.2845insA is a recurring mutation with a founder effect in Singapore Malay women with early onset breast/ovarian cancer.
    Sng JH; Ali AB; Lee SC; Zahar D; Wong JE; Blake V; Sharif A; Cross G; Iau PT
    J Med Genet; 2003 Oct; 40(10):e117. PubMed ID: 14569140
    [No Abstract]   [Full Text] [Related]  

  • 2. BRCA1 c.2845insA is a founder mutation in Singaporean Malay women with early onset breast/ovarian cancer.
    Sng JH; Ali AB; Lee SC; Zahar D; Wong JE; Cross G; Iau PT
    Ann Acad Med Singap; 2003 Sep; 32(5 Suppl):S53-5. PubMed ID: 14968737
    [No Abstract]   [Full Text] [Related]  

  • 3. BRCA1 disease-associated haplotypes in Singapore Malay women with early-onset breast/ovarian cancer.
    Ali AB; Iau PT; Putti TC; Sng JH
    Breast Cancer Res Treat; 2007 Sep; 104(3):351-3. PubMed ID: 17406974
    [No Abstract]   [Full Text] [Related]  

  • 4. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
    Tonin PN
    Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Founder mutation in the BRCA1 gene in Malay breast cancer patients from Singapore.
    Lee AS; Ho GH; Oh PC; Balram C; Ooi LL; Lim DT; Wong CY; Hong GS
    Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
    Phelan CM; Kwan E; Jack E; Li S; Morgan C; Aubé J; Hanna D; Narod SA
    Hum Mutat; 2002 Nov; 20(5):352-7. PubMed ID: 12402332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania.
    Elsakov P; Kurtinaitis J; Petraitis S; Ostapenko V; Razumas M; Razumas T; Meskauskas R; Petrulis K; Luksite A; Lubiński J; Górski B; Narod SA; Gronwald J
    Clin Genet; 2010 Oct; 78(4):373-6. PubMed ID: 20345474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families.
    Kauff ND; Perez-Segura P; Robson ME; Scheuer L; Siegel B; Schluger A; Rapaport B; Frank TS; Nafa K; Ellis NA; Parmigiani G; Offit K
    J Med Genet; 2002 Aug; 39(8):611-4. PubMed ID: 12161607
    [No Abstract]   [Full Text] [Related]  

  • 9. The contribution of founder mutations in BRCA1 to breast cancer in Belarus.
    Uglanitsa N; Oszurek O; Uglanitsa K; Savonievich E; Lubiński J; Cybulski C; Debniak T; Narod SA; Gronwald J
    Clin Genet; 2010 Oct; 78(4):377-80. PubMed ID: 20507347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history.
    Anagnostopoulos T; Pertesi M; Konstantopoulou I; Armaou S; Kamakari S; Nasioulas G; Athanasiou A; Dobrovic A; Young MA; Goldgar D; Fountzilas G; Yannoukakos D
    Breast Cancer Res Treat; 2008 Jul; 110(2):377-85. PubMed ID: 17902052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas.
    Donenberg T; Lunn J; Curling D; Turnquest T; Krill-Jackson E; Royer R; Narod SA; Hurley J
    Breast Cancer Res Treat; 2011 Jan; 125(2):591-6. PubMed ID: 20838878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
    Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.
    Bogdanova NV; Antonenkova NN; Rogov YI; Karstens JH; Hillemanns P; Dörk T
    Clin Genet; 2010 Oct; 78(4):364-72. PubMed ID: 20569256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is BRCA1 associated with familial breast cancer in India?
    Couch FJ
    Cancer Biol Ther; 2002; 1(1):22-3. PubMed ID: 12197480
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer.
    Kadouri L; Bercovich D; Elimelech A; Lerer I; Sagi M; Glusman G; Shochat C; Korem S; Hamburger T; Nissan A; Abu-Halaf N; Badrriyah M; Abeliovich D; Peretz T
    BMC Cancer; 2007 Jan; 7():14. PubMed ID: 17233897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
    Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M
    Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel and common BRCA1 mutations in familial breast/ovarian cancer patients from Lithuania.
    Janavicius R; Pepalyte I; Kucinskas V
    Breast Cancer Res Treat; 2009 Sep; 117(2):467-9. PubMed ID: 18763032
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado.
    Mullineaux LG; Castellano TM; Shaw J; Axell L; Wood ME; Diab S; Klein C; Sitarik M; Deffenbaugh AM; Graw SL
    Cancer; 2003 Aug; 98(3):597-602. PubMed ID: 12879478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sequence analysis of BRCA1 gene in young breast cancer patients and/or positive family history].
    Hampl M; Plaschke J; Burgemeister R; Schwarz P; Saeger HD; Schackert HK
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):267-72. PubMed ID: 14518257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of the BRCA1 del (exons 9-12) mutation in breast/ovarian cancer families outside of Mexican Hispanics.
    Torres D; Rashid MU; ; Seidel-Renkert A; Weitzel JN; Briceno I; Hamann U
    Breast Cancer Res Treat; 2009 Oct; 117(3):679-81. PubMed ID: 19333752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.